U.S. FDA Steps Up Scrutiny of Imported Drugs

The U.S. FDA says it is taking several steps to ensure that imported drugs meet the same rigorous standards for safety and quality as those manufactured domestically. The FDA detailed its activities and strategies in a new report. Each year from 2005-2011, imports of pharmaceutical products have increased by nearly 13%, FDA says. More than 80% of the active pharmaceutical ingredients (APIs) used to make medicines in the U.S. and 40% of finished dosage drugs consumed in the U.S. are imported, FDA says. Over the next decade, FDA says it will continue to transform...

If you have already signed up for access to Chemical Week Regulatory Watch, please log in here.

Forgot your user ID or password?
Click here to have it sent to you.